Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 133

Results For "process"

1576 News Found

USFDA approves IND application for Allied’s cancer treatment
Biotech | January 24, 2022

USFDA approves IND application for Allied’s cancer treatment

APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types


Advent to acquire controlling stake in Avra Labs
News | January 24, 2022

Advent to acquire controlling stake in Avra Labs

Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh


DefiniGen promotes Dr Chris Kirton to CEO
People | January 21, 2022

DefiniGen promotes Dr Chris Kirton to CEO

The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening


Dolomite Bio announce launch of cost-effective Bioinformatics service
Biotech | January 20, 2022

Dolomite Bio announce launch of cost-effective Bioinformatics service

Unlike most data analysis services, Dolomite Bio will accept sample sizes ranging from as little as one sample, to as many as the research project requires


Zydus receives final approval from USFDA for Vigabatrin tablets
Drug Approval | January 20, 2022

Zydus receives final approval from USFDA for Vigabatrin tablets

Vigabatrin is an anticonvulsant. It is known to work by stopping the breakdown of a natural calming substance (GABA) in the brain


Green chemistry approaches to synthesis could make a big difference to pharma product outputs
News | January 20, 2022

Green chemistry approaches to synthesis could make a big difference to pharma product outputs

Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies


China approves MIOK Keratoprosthesis’ artificial cornea
Biotech | January 19, 2022

China approves MIOK Keratoprosthesis’ artificial cornea

The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness


Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore
News | January 18, 2022

Lupin to acquire supplements portfolio of Anglo-French Drugs & Industries for Rs 325 crore

The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category


Philips integrates cloud-based AI and 3D mapping into Zenition
Digitisation | January 18, 2022

Philips integrates cloud-based AI and 3D mapping into Zenition

New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment


AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments
Biotech | January 14, 2022

AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments

The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival